Caroline Chung, MD, MSc., FRCPC, CIP

Peer-Reviewed Articles

1. Guran E, Hu J, Wefel JS, Chung C, Cata JP. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review. Br J Anaesth 129(6):909-922, 2022. e-Pub 2022. PMID: 36270848.
2. Aminu M, Yadav D, Hong L, Young E, Edelkamp P, Saad M, Salehjahromi M, Chen P, Sujit SJ, Chen MM, Sabloff B, Gladish G, de Groot PM, Godoy MCB, Cascone T, Vokes NI, Zhang J, Brock KK, Daver N, Woodman SE, Tawbi HA, Sheshadri A, Lee JJ, Jaffray D, D Code Team , Wu CC, Chung C, Wu J. Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19. Cancers (Basel) 15(1), 2022. e-Pub 2022. PMID: 36612278.
3. Netherton TJ, Nguyen C, Cardenas CE, Chung C, Klopp AH, Colbert LE, Rhee DJ, Peterson CB, Howell R, Balter P, Court LE. An Automated Treatment Planning Framework for Spinal Radiation Therapy and Vertebral-Level Second Check. Int J Radiat Oncol Biol Phys 114(3):516-528, 2022. e-Pub 2022. PMID: 35787928.
4. Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Alfred Yung WK, van den Bent M, Wen PY, Cloughesy TF. Hypothetical Generalized Framework for a New Imaging Endpoint of Therapeutic Activity in Early Phase Clinical Trials in Brain Tumors. Neuro Oncol 24(8):1219-1229, 2022. e-Pub 2022. PMID: 35380705.
5. Hormuth DA, Farhat M, Christenson C, Curl B, Chad Quarles C, Chung C, Yankeelov TE. Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy. Adv Drug Deliv Rev 187:114367, 2022. e-Pub 2022. PMID: 35654212.
6. Wu C, Lorenzo G, Hormuth DA, Lima EABF, Slavkova KP, DiCarlo JC, Virostko J, Phillips CM, Patt D, Chung C, Yankeelov TE. Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology. Biophys Rev (Melville) 3(2):021304, 2022. e-Pub 2022. PMID: 35602761.
7. Butner JD, Dogra P, Chung C, Ruiz-Ramírez J, Nizzero S, Plodinec M, Li X, Pan PY, Chen SH, Cristini V, Ozpolat B, Calin GA, Wang Z. Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study. Cell Death Dis 13(5):485, 2022. e-Pub 2022. PMID: 35597788.
8. Buchsbaum JC, Jaffray DA, Ba D, Borkon LL, Chalk C, Chung C, Coleman MA, Coleman CN, Diehn M, Droegemeier KK, Enderling H, Espey MG, Greenspan EJ, Hartshorn CM, Hoang T, Hsiao HT, Keppel C, Moore NW, Prior F, Stahlberg EA, Tourassi G, Willcox KE. Predictive Radiation Oncology - A New NCI-DOE Scientific Space and Community. Radiat Res 197(4):434-445, 2022. e-Pub 2022. PMID: 35090025.
9. Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease. Front Oncol 12:849993, 2022. e-Pub 2022. PMID: 35371980.
10. Kim Y, Zhu L, Zhu H, Li X, Huang Y, Gu C, Bush H, Chung C, Zhang GQ. Characterizing cancer and COVID-19 outcomes using electronic health records. PLoS One 17(5):e0267584, 2022. e-Pub 2022. PMID: 35507598.
11. Chung C, Jaffray DA. Cancer Needs a Robust "Metadata Supply Chain" to Realize the Promise of Artificial Intelligence. Cancer Res 81(23):5810-5812, 2021. PMID: 34853038.
12. Kothari AN, DiBrito SR, Lee JJ, Caudle AS, Clemens MW, Gottumukkala VN, Katz MHG, Offodile AC, Uppal A, D3CODE Team, Chang GJ. Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection. Ann Surg Oncol 28(13):8046-8053, 2021. e-Pub 2021. PMID: 34176060.
13. Chung C, Brown PD, Wefel JS. Short reply to "Proton therapy for newly diagnosed glioblastoma: More room for investigation" by R. Press et al. Neuro Oncol 23(11):1982, 2021. e-Pub 2021. PMID: 34453547.
14. Kotla S, Zhang A, Imanishi M, Ko KA, Lin SH, Gi YJ, Moczygemba M, Isgandarova S, Schadler KL, Chung C, Milgrom SA, Banchs J, Yusuf SW, Amaya DN, Guo H, Thomas TN, Shen YH, Deswal A, Herrmann J, Kleinerman ES, Entman ML, Cooke JP, Schifitto G, Maggirwar SB, McBeath E, Gupte AA, Krishnan S, Patel ZS, Yoon Y, Burks JK, Fujiwara K, Brookes PS, Le NT, Hamilton DJ, Abe JI. Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. Redox Biol 47:102132, 2021. e-Pub 2021. PMID: 34619528.
15. Butner JD, Martin GV, Wang Z, Corradetti B, Ferrari M, Esnaola N, Chung C, Hong DS, Welsh JW, Hasegawa N, Mittendorf EA, Curley SA, Chen SH, Pan PY, Libutti SK, Ganesan S, Sidman RL, Pasqualini R, Arap W, Koay EJ, Cristini V. Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling. Elife 10, 2021. e-Pub 2021. PMID: 34749885.
16. Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, Mahajan A, Li J, McGovern SL, McAleer MF, Ghia AJ, Sulman EP, Penas-Prado M, de Groot JF, Heimberger AB, Wang J, Armstrong TS, Gilbert MR, Guha-Thakurta N, Wefel JS. A Prospective Phase II Randomized Trial of Proton Radiotherapy vs. Intensity Modulated Radiotherapy for Patients with Newly Diagnosed Glioblastoma. Neuro Oncol 23(8):1337-1347, 2021. e-Pub 2021. PMID: 33647972.
17. Wang J, Salzillo T, Jiang Y, Mackeyev Y, David Fuller C, Chung C, Choi S, Hughes N, Ding Y, Yang J, Vedam S, Krishnan S. Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac. Radiother Oncol 161:55-64, 2021. e-Pub 2021. PMID: 34089753.
18. Thrower SL, Al Feghali KA, Luo D, Paddick I, Hou P, Briere T, Li J, McAleer MF, McGovern SL, Woodhouse KD, Yeboa DN, Brock KK, Chung C. The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery. Adv Radiat Oncol 6(4):100708, 2021. e-Pub 2021. PMID: 34124413.
19. McGee KP, Hwang KP, Sullivan DC, Kurhanewicz J, Hu Y, Wang J, Li W, Debbins J, Paulson E, Olsen JR, Hua CH, Warner L, Ma D, Moros E, Tyagi N, Chung C. Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294. Med Phys 48(7):e697-e732, 2021. e-Pub 2021. PMID: 33864283.
20. Butner JD, Wang Z, Elganainy D, Al Feghali KA, Plodinec M, Calin GA, Dogra P, Nizzero S, Ruiz-Ramírez J, Martin GV, Tawbi HA, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V. A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Nat Biomed Eng 5(4):297-308, 2021. e-Pub 2021. PMID: 33398132.
21. Al Feghali KA, Buszek SM, Elhalawani H, Chevli N, Allen PK, Chung C. Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status. Neurooncol Pract 8(2):199-208, 2021. e-Pub 2020. PMID: 33898053.
22. Hormuth DA, Al Feghali KA, Elliott AM, Yankeelov TE, Chung C. Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation. Sci Rep 11(1):8520, 2021. e-Pub 2021. PMID: 33875739.
23. Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, McGovern SL, Grassberger C, Shih H, Ellsworth S, Grosshans DR. Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons. Neuro Oncol 23(2):284-294, 2021. e-Pub 2020. PMID: 32750703.
24. Massaad E, Hamidi N, Goetz J, Padmanaban V, Mau C, Tsang D, de Moraes FY, Chung C, Zacharia BE, Mansouri A. Equivalent efficacy and safety of radiosurgery for cystic and solid vestibular schwannomas: A systematic review. World Neurosurg 146:322-331.e1, 2021. e-Pub 2020. PMID: 33212274.
25. SandstrÖm H, Toma-Dasu I, Chung C, GÅrding J, Jokura H, Dasu A. Simultaneous Truth and Performance Level Estimation Method for Evaluation of Target Contouring in Radiosurgery. Anticancer Res 41(1):279-288, 2021. PMID: 33419822.
26. Jhawar SR, Palmer JD, Wang SJ, Bitterman D, Klamer B, Huynh-Le M, Chung C, Ohri N, Stover DG, Lustberg MB, Mishra S, Warner J, Jabbour S, Goyal S, CCC19 Radiation Oncology Group. The COVID-19 & Cancer Consortium (CCC19) and Opportunities for Radiation Oncology. Adv Radiat Oncol 6(1):100614, 2021. e-Pub 2020. PMID: 33521393.
27. Hormuth DA, Jarrett AM, Lorenzo G, Lima EABF, Wu C, Chung C, Patt D, Yankeelov TE. Math, magnets, and medicine: enabling personalized oncology. Expert Rev Precis Med Drug Dev 6(2):79-81, 2021. e-Pub 2021. PMID: 34027102.
28. Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, Wang J, de Groot J, Heimberger AB, Armstrong TS, Gilbert MR, Mahajan A, Guha-Thakurta N, Chung C. Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neurooncol Adv 3(1):vdab073, 2021. e-Pub 2021. PMID: 34337411.
29. Zakaria R, Radon M, Mills S, Mitchell D, Palmieri C, Chung C, Jenkinson MD. The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy. Front Oncol 11:711405, 2021. e-Pub 2021. PMID: 34765539.
30. Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. Response to Letter to Editor. Neuro Oncol 22(11):1706-1707, 2020. PMID: 32823280.
31. Netherton TJ, Rhee DJ, Cardenas CE, Chung C, Klopp AH, Peterson CB, Howell RM, Balter PA, Court LE. Evaluation of a multiview architecture for automatic vertebral labeling of palliative radiotherapy simulation CT images. Med Phys 47(11):5592-5608, 2020. e-Pub 2020. PMID: 33459402.
32. Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg 141:e133-e144, 2020. e-Pub 2020. PMID: 32407910.
33. Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. Consensus Recommendations for a Dynamic Susceptibility Contrast MRI Protocol for Use in High-Grade Gliomas. Neuro Oncol 22(9):1262-1275, 2020. e-Pub 2020. PMID: 32516388.
34. Tseng CL, Stewart J, Whitfield G, Verhoeff JJC, Bovi J, Soliman H, Chung C, Myrehaug S, Campbell M, Atenafu EG, Heyn C, Das S, Perry J, Ruschin M, Sahgal A. Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow. J Neurooncol 149(2):305-314, 2020. e-Pub 2020. PMID: 32860571.
35. Slagowski JM, Ding Y, Aima M, Wen Z, Fuller CD, Chung C, Debnam JM, Hwang KP, Kadbi M, Szklaruk J, Wang J. A modular phantom and software to characterize 3D geometric distortion in MRI. Phys Med Biol 65(19):195008, 2020. e-Pub 2020. PMID: 32531763.
36. Jain AK, Aneja S, Fuller CD, Dicker AP, Chung C, Kim E, Kirby JS, Quon H, Lam CJK, Louv WC, Ahern C, Xiao Y, McNutt TR, Housri N, Ennis RD, Kang J, Tang Y, Higley H, Berny-Lang MA, Camphausen KA. Provider Engagement in Radiation Oncology Data Science: Workshop Report. JCO Clin Cancer Inform 4:700-710, 2020. PMID: 32755458.
37. Zaid M, Koay EJ, Bajaj N, Mathew R, Xiao L, Agrawal A, Fernandes P, Burrows H, Roach MA, Wilke CT, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS. A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Oral Oncol 106:104665, 2020. e-Pub 2020. PMID: 32298994.
38. Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol 5(4):743-745, 2020. e-Pub 2020. PMID: 32775785.
39. Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM). Neuro Oncol 22(6):757-772, 2020. PMID: 32048719.
40. Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Neuro Oncol 22(4):577-579, 2020. e-Pub 2020. PMID: 31900480.
41. Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database. Sci Rep 10(1):4926, 2020. e-Pub 2020. PMID: 32188907.
42. Jin Y, Randall JW, Elhalawani H, Feghali KAA, Elliott AM, Anderson BM, Lacerda L, Tran BL, Mohamed AS, Brock KK, Fuller CD, Chung C. Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging. Cancers (Basel) 12(3), 2020. e-Pub 2020. PMID: 32121471.
43. McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR, Shen C, Kleinberg L, Contessa JN, Corso C, Chiang V, Henson-Masters A, Cramer CK, Ruiz J, Pasche B, Watabe K, D'Agostino R, Su J, Laxton AW, Tatter SB, Fiveash JB, Ahluwalia M, Kotecha R, Chao ST, Braunstein SE, Attia A, Chung C, Chan MD. Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery. Radiother Oncol 142:168-174, 2020. e-Pub 2019. PMID: 31526671.
44. Esho TO, Chung C, Thompson JU, Dehghanpour M, Sutton JR, Shaitelman SF, Kisling KK, Court LE. Optimization of autogenerated chest-wall radiation treatment plans developed for postmastectomy breast cancer patients in underserved clinics. Med Dosim 45(1):102-107, 2020. e-Pub 2020. PMID: 31956001.
45. Kuhn T, Jin Y, Huang C, Kim Y, Nir TM, Gullett JM, Jones JD, Sayegh P, Chung C, Dang BH, Singer EJ, Shattuck DW, Jahanshad N, Bookheimer SY, Hinkin CH, Zhu H, Thompson PM, Thames AD. The Joint Effect of Aging and HIV Infection on Microstructure of White Matter Bundles. Hum Brain Mapp 40(15):4370-4380, 2019. e-Pub 2019. PMID: 31271489.
46. Milgrom SA, Varghese B, Gladish GW, Choi AD, Dong W, Patel ZS, Chung CC, Rao A, Pinnix CC, Gunther JR, Dabaja BS, Lin SH, Hoffman KE, Huff JL, Slagowski J, Abe JI, Iliescu CA, Banchs J, Yusuf SW, Lopez-Mattei JC. Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy. J Cardiovasc Imaging 27(4):268-279, 2019. PMID: 31614398.
47. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol 16(8):521-522, 2019. PMID: 31150024.
48. Zaid M, Bajaj N, Burrows H, Mathew R, Dai A, Wilke CT, Palasi S, Hergenrother R, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS, Koay EJ. Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. Radiat Oncol 14(1):148, 2019. e-Pub 2019. PMID: 31426824.
49. Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, Chao S, Attia A, Ayala-Peacock DN, Chan MD. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience. Int J Radiat Oncol Biol Phys 104(5):1091-1098, 2019. e-Pub 2019. PMID: 30959122.
50. Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, Huang W, Noworolski SM, Young RJ, Shiroishi MS, Kim H, Coolens C, Laue H, Chung C, Rosen M, Boss M, Jackson EF. Quantitative Imaging Biomarkers Alliance (QIBA) Recommendations for Improved Precision of DWI and DCE-MRI Derived Biomarkers in Multicenter Oncology Trials. J Magn Reson Imaging 49(7):e101-e121, 2019. e-Pub 2018. PMID: 30451345.
51. Bliesener Y, Zhong X, Guo Y, Boss M, Bosca R, Laue H, Chung C, Sung K, Nayak KS. Radiofrequency transmit calibration: A multi-center evaluation of vendor-provided radiofrequency transmit mapping methods. Med Phys 46(6):2629-2637, 2019. e-Pub 2019. PMID: 30924940.
52. Coolens C, Driscoll B, Foltz W, Svistoun I, Sinno N, Chung C. Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer. Br J Radiol 92(1096):20170461, 2019. e-Pub 2019. PMID: 30235004.
53. Buszek SM, Ikner S, Wiedemann L, Wang J, McAleer MF, Grosshans DR, Paulino AC, McGovern SL, Chung C. Safety and Feasibility of Magnetic Resonance Imaging Simulation for Radiation Treatment Planning in Pediatric Patients: A Single Institution Experience. Adv Radiat Oncol 4(2):362-366, 2019. e-Pub 2018. PMID: 31011682.
54. Foltz W, Driscoll B, Laurence Lee S, Nayak K, Nallapareddy N, Fatemi A, Ménard C, Coolens C, Chung C. Phantom Validation of DCE-MRI Magnitude and Phase-Based Vascular Input Function Measurements. Tomography 5(1):77-89, 2019. PMID: 30854445.
55. Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado M. RBM10 Truncation in Astroblastoma in a Patient with History of Mandibular Ameloblastoma: A case report. Cancer Genet 231-232:41-45, 2019. e-Pub 2019. PMID: 30803556.
56. Papadakos J, Agarwal A, Charow R, Quartey NK, D'souza A, Giuliani M, Millar BA, Massey C, Shultz D, Chung C. Informational needs of brain metastases patients and their caregivers. Neurooncol Pract 6(1):47-60, 2019. e-Pub 2018. PMID: 31386069.
57. Sandström H, Jokura H, Chung C, Toma-Dasu I. Multi-institutional study of the variability in target delineation for six targets commonly treated with radiosurgery. Acta Oncol 57(11):1-6, 2018. e-Pub 2018. PMID: 29786462.
58. Patel A, Dong T, Ansari S, Cohen-Gadol A, Watson GA, Moraes FY, Nakamura M, Murovic J, Chang SD, Hatiboglu MA, Chung C, Miller JC, Lautenschlaeger T. Toxicity of Radiosurgery for Brainstem Metastases. World Neurosurg 119:e757-e764, 2018. e-Pub 2018. PMID: 30096494.
59. Sandstrom H, Jokura H. Chung C, Yoma-Dasu I,. Simultaneous truth and performance level estimation method for evaluation of target contouring in radiosurgery - feasibility test and robustness analysis. Acta Oncologica 57(11):1515-1520, 2018. PMID: 29786462.
60. Chung C, Bryant A, Brown PD. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. Cochrane Database Syst Rev 7:CD011492, 2018. e-Pub 2018. PMID: 29987845.
61. Al Feghali KA, Hilal L, Chung C. Review of Intracranial Meningiomas: An Update on Management from Diagnosis to Treatment. Internal Medicine Review, 2018.
62. McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M. Multi-Institutional Competing Risks Analysis of Distant Brain Failure and Salvage Patterns after Upfront Radiosurgery without Whole Brain Radiotherapy for Brain Metastasis. Ann Oncol 29(2):497-503, 2018. e-Pub 2017. PMID: 29161348.
63. Al Feghali KA, Yeboa DN, Chasen B, Gule MK, Johnson JM, Chung C. The Use of 68Ga-DOTATATE PET/CT in the Non-Invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Front Oncol 8:454, 2018. e-Pub 2018. PMID: 30386741.
64. Winter JD, Moraes FY, Chung C, Coolens C. Detectability of radiation-induced changes in magnetic resonance biomarkers following stereotactic radiosurgery: A pilot study. PLoS One 13(11):e0207933, 2018. e-Pub 2018. PMID: 30475887.
65. Maqbool T, Agarwal A, Sium A, Trang A, Chung C, Papadakos J. Informational and Supportive Care Needs of Brain Metastases Patients and Caregivers: a Systematic Review. J Cancer Educ 32(4):914-923, 2017. e-Pub 2016. PMID: 27041700.
66. Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG, Deming R, Dixon JG, Burri SH, Chung C, Ménard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. Int J Radiat Oncol Biol Phys 99(5):1173-1178, 2017. e-Pub 2017. PMID: 28939223.
67. Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, Kleinberg L, Shen C, Taylor RB, Onyeuku NE, Hyde AT, Gorovets D, Chao ST, Corso C, Ruiz J, Watabe K, Tatter SB, Zadeh G, Chiang VLS, Fiveash JB, Chan MD. Prediction of New Brain Metastases after Radiosurgery: Validation and Analysis of Performance of a Multi-Institutional Nomogram. J Neurooncol 135(2):403-411, 2017. e-Pub 2017. PMID: 28828698.
68. Hahn E, Laperriere N, Krema H, Velazquez-Martin JP, Somani S, Waldron J, Simpson R, Payne D, Chung C. Clinical outcomes of hypofractionated radiation therapy for choroidal metastases: Symptom palliation, tumor control, and survival. Pract Radiat Oncol 7(6):388-395, 2017. e-Pub 2017. PMID: 28867543.
69. Chung C, Brock K. Image-guided radiation therapy: looking beyond what we currently see. Future Oncol 13(26):2317-2319, 2017. e-Pub 2017. PMID: 29121781.
70. Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ. Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol 10(3):2375-2, 2017. e-Pub 2017. PMID: 28382534.
71. Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuth DA, Houdt PJV, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. A multi-institutional comparison of dynamic contrast-enhanced magnetic resonance imaging parameter calculations. Sci Rep 7(1):11185, 2017. e-Pub 2017. PMID: 28894197.
72. Murray L, Longo J, Wan J, Chung C, Wang L, Dawson L, Milosevic M, Oza A, Brade A. Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): The TAP study. Radiother Oncol 124(1):74-79, 2017. e-Pub 2017. PMID: 28668472.
73. Moraes FY, Chung C. Radiation for Skull Base Meningiomas: Review of the Literature on the Approach to Radiotherapy. Chin Clin Oncol 6((Suppl 1):S3):S3, 2017. PMID: 28758407.
74. Mason M, Maurice C, McNamara MG, Tieu MT, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Atenafu EG, Mason W, Chung C. Neutrophil-Lymphocyte Ratio Dynamics during Concurrent Chemo-radiotherapy for Glioblastoma is an Independent Predictor for Overall Survival. J Neurooncol 132(3):463-471, 2017. e-Pub 2017. PMID: 28332000.
75. Doherty MK, Korpanty GJ, Tomasini P, Alizadeh M, Jao K, Labbé C, Mascaux CM, Martin P, Kamel-Reid S, Tsao MS, Pintilie M, Liu G, Bradbury PA, Feld R, Leighl NB, Chung C, Shepherd FA. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer. Radiother Oncol 123(2):195-202, 2017. e-Pub 2017. PMID: 28363487.
76. McNamara MG, Jiang H, Lim-Fat MJ, Sahebjam S, Kiehl TR, Karamchandani J, Coire C, Chung C, Millar BA, Laperriere N, Mason WP. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas. Can J Neurol Sci 44(3):288-294, 2017. PMID: 28488951.
77. Kerbauy MN, Moraes FY, Lok BH, Ma J, Kerbauy LN, Spratt DE, Santos FP, Perini GF, Berlin A, Chung C, Hamerschlak N, Yahalom J. Challenges and Opportunities in Primary CNS Lymphoma: a systematic review. Radiother Oncol 122(3):352-361, 2017. e-Pub 2017. PMID: 28104300.
78. Murray L, Menard C, Zadeh G, Au K, Bernstein M, Millar BA, Laperriere N, Chung C. Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review. J Radiat Oncol 6(1):1-10, 2017. e-Pub 2016. PMID: 28367275.
79. Wilke CT, Zaid M, Chung C, Fuller CD, Mohamed ASR, Skinner H, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Chambers MS, Koay EJ. Design and fabrication of a 3D-printed oral stent for head and neck radiotherapy from routine diagnostic imaging. 3D Print Med 3(1):12, 2017. e-Pub 2017. PMID: 29782600.
80. Sandström H, Chung C, Jokura H, Torrens M, Jaffray D, Toma-Dasu I. Assessment of organs-at-risk contouring practices in radiosurgery institutions around the world - The first initiative of the OAR Standardization Working Group. Radiother Oncol 121(2):180-186, 2016. e-Pub 2016. PMID: 27816408.
81. Li W, Cho YB, Ansell S, Laperriere N, Ménard C, Millar BA, Zadeh G, Kongkham P, Bernstein M, Jaffray DA, Chung C. The Use of Cone-Beam Computed Tomography for Image-Guided Gamma Knife Stereotactic Radiosurgery: Initial Clinical Evaluation. Int J Radiat Oncol Biol Phys 96(1):214-20, 2016. e-Pub 2016. PMID: 27511857.
82. Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG, Deming R, Burri SH, Ménard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 316(4):401-409, 2016. PMID: 27458945.
83. Li W, Bootsma G, Von Schultz O, Carlsson P, Laperriere N, Millar BA, Jaffray D, Chung C. Preliminary Evaluation of a Novel Thermoplastic Mask System with Intra-fraction Motion Monitoring for Future Use With Image-Guided Gamma Knife. Cureus 8(3):e531, 2016. e-Pub 2016. PMID: 27081592.
84. Adilman R, Rajmohan Y, Brooks E, Urgoiti GR, Chung C, Hammad N, Trinkaus M, Naseem M, Simmons C, Adilman R, Rajmohan Y, Brooks E, Roldan Urgoiti G, Chung C, Hammad N, Trinkaus M, Naseem M, Simmons C. Social Media Use Among Physicians and Trainees: Results of a National Medical Oncology Physician Survey. J Oncol Pract 12(1):79-80, e52-60, 2016. e-Pub 2015. PMID: 26443837.
85. Li W, Cho YB, Ansell S, Laperriere N, Menard C, Millar BA, Zadeh G, Kongkham P, Bernstein M, Jaffray D, Chung C. Image-Guidance for Gamma Knife Stereotactic Radiosurgery Using Cone-Beam Computed Tomography. Int J Radiat Oncol Biol Phys 96(1):214-220, 2016.
86. Cho YB, Laperriere N, Hodaie M, Chung C. Hybrid isocenter technique for Gamma-Knife Perfexion treatment of trigeminal neuralgia. Med Dosim 41(4):271-276, 2016. PMID: 27839588.
87. Hussein H, Chung C, Moshonov H, Miller N, Kulkarni SR, Scaranelo AM. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast. Acad Radiol 22(12):1483-8, 2015. e-Pub 2015. PMID: 26391856.
88. Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol 17(9):1188-98, 2015. e-Pub 2015. PMID: 26250565.
89. Tieu MT, Lovblom LE, McNamara MG, Mason W, Laperriere N, Millar BA, Ménard C, Kiehl TR, Perkins BA, Chung C. Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide. J Neurooncol 124(1):119-126, 2015. e-Pub 2015. PMID: 26015297.
90. Armstrong TS, Ying Y, Wu J, Acquaye AA, Vera-Bolanos E, Gilbert MR, Brown PD, Vardy J, Chung C. The Relationship between Corticosteroids and Symptoms in Patients with Primary Brain Tumors-Utility of the Dexamethasone Symptom Questionnaire-Chronic. Neuro Oncol 17(8):1114-1120, 2015. e-Pub 2015. PMID: 25862766.
91. Wazer DE, Hepel JT, Riker AI, Harness JK, Chung C, Khan AJ, Offersen BV, Poortmans P, Taghian A. In Regard to Vaidya et al. Int J Radiat Oncol Biol Phys 92(5):952-953, 2015. e-Pub 2015. PMID: 26194662.
92. Chung C, Torrens M, Paddick I, Ryu S, Hanssens P, Jaffray D. Radiosurgery Nomenclature: A Confusion of Tongues. Int J Radiat Oncol Biol Phys 25(3):119-126, 2015. PMID: 26068485.
93. Chung C, Metser U, Ménard C. Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma. Semin Radiat Oncol 25(3):164-71, 2015. e-Pub 2015. PMID: 26050586.
94. Sahgal A, Chan MW, Atenafu EG, Masson-Cote L, Bahl G, Yu E, Millar BA, Chung C, Catton C, O’Sullivan B, Irish JC, Gilbert R, Zadeh G, Cusimano M, Gentili F, Laperriere NJ. Image-guided intensity modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes. Neuro Oncol 17(6):889-94, 2015.
95. Lymberiou T, Galuszka S, Lee G, Xu W, Su S, Fyles A, Purdie T, Catton P, Chung C, Dinniwell R, Han K, Koch A, Levin W, Manchul L, Sappiatzer J, Mackenzie P, Liu FF. Predictors of Breast Radiotherapy Plan Modifications: Quality Assurance Rounds in a Large Cancer Centre. Radiother Oncol 114(1):17-21, 2015.
96. Coolens C, Driscoll B, Chung C, Shek T, Gorjizadeh A, Ménard C, Jaffray D. Automated Voxel-Based Analysis of Volumetric Dynamic Contrast-Enhanced CT Data Improves Measurement of Serial Changes in Tumor Vascular Biomarkers. Int J Radiat Biol Phys 91(1):48-57, 2015. PMID: 25446606.
97. Torrens M, Chung C, Chung HT, Hanssens P, Jaffray D, Kemeny A, Larson D, Levivier M, Lindquist C, Lippitz B, Novotny J, Paddick I, Prasad D, Yu CP. The standardization of terminology in stereotactic radiosurgery: report from the standardization committee of the International Leksell Gamma Knife®Society. J Neurosurg 121(Suppl):2-15, 2014. PMID: 25587587.
98. Jalali S, Chung C, Foltz W, Burrell K, Singh S, Hill R, Zadeh G. MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy. NeuroOncology 16(6):868-79, 2014. e-Pub 2014. PMID: 24759636.
99. Mackenzie P, Fyles A, Wang W, Chung C. Advanced radiotherapy techniques for breast cancer to minimize cardiovascular risk. Breast Cancer Management 3(3):297-305, 2014. PMID: 21237584.
100. McNamara MG, Lwin Z, Jiang H, Templeton AJ, Zadeh G, Bernstein M, Chung C, Millar BA, Laperriere N, Mason WP. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression. J Neurooncol 117(1):147-52, 2014.
101. McNamara MG, Lwin Z, Jiang H, Chung C, Millar BA, Sahgal A, Laperriere N, Mason WP. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era. J Neurooncol 117(1):153-60, 2014.
102. Kurtz G, Zadeh G, Gingras-Hill G, Millar BA, Laperriere NJ, Bernstein M, Jiang H, Ménard C, Chung C. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection. Int J Radiat Oncol Biol Phys 88(1):137-42, 2014.
103. Tieu MT, Lovblom LE, MacNamara M, Mason W, Kiehl R, Rodin D, Laperriere N, Millar BA, Menard C, Perkins B, Chung C. Glycemia Impacts Survival of Glioblastoma Patients Treated with Radiation and Temozolomide. Journal of Neurooncology, 2014.
104. Hahn E, Velazquez-Martin JP, Somani S, Payne D, Waldron J, Krema H, Simpson R, Laperriere N, Chung C. Palliative radiotherapy for choroidal metastases: Clinical outcomes and predictors of overall survival. Practical Radiation Oncology 4(4):233-9, 2014.
105. Chung C, Mason. Salvage radiosurgery for high grade glioma in the era of modern systemic therapy. Can J Neurol Sci 40(6):761-2, 2013.
106. Little A , Chung C, Perez-Ordonez B , Mikulis D , Valiante TA. High-grade intracranial chondrosarcoma presenting with haemorrhage. J Clin Neurosci 97(6):730-4, 2013.
107. Krema H, Herrmann E, Albert-Green A, Payne D, Laperriere N, Chung C. Orthovoltage Radiotherapy in the Management of Medical Canthal Basal Cell Carcinoma. Br J Opthalmology 97(6):730-4, 2013.
108. Chung C, Jalali S, Foltz W, Burrell K, Wildgoose P, Lindsay P, Graves C, Camphausen K, Milosevic M, Jaffray D, Zadeh G, Ménard C. Imaging Biomarker Dynamics in an Intracranial Murine Glioma Study of Radiation and Antiangiogenic Therapy. Int J Radiat Oncol Biol Phys 85(3):805-12, 2013. e-Pub 2012. PMID: 22929856.
109. Ebinu JO, Lwu S, Monsalves E, Arayee M, Chung C, Laperriere NJ, Kulkarni AV, Goetz P, Zadeh G. Gamma Knife Radiosurgery for the Treatment of Cystic Cerebral Metastases. Int J Radiat Oncol Biol Phys 85(3):667-71, 2013. e-Pub 2012. PMID: 22885145.
110. Lwu S, Goetz P, Monsalves E, Aryaee M, Ebinu J, Laperriere N, Menard C, Chung C, Millar BA, Kulkarni AV, Bernstein M, Zadeh G. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases. Oncol Rep 29(2):407-12, 2013. e-Pub 2012. PMID: 23151681.
111. Ruschin M, Komljenovic PT, Ansell S, Ménard C, Bootsma G, Cho YB, Chung C, Jaffray D. Cone Beam Computed Tomography Image Guidance System for a Dedicated Intracranial Radiosurgery Treatment Unit. Int J Radiat Oncol Biol Phys 85(1):243-250, 2013. e-Pub 2012. PMID: 22560556.
112. Ruschin M, De Jean P, Ansell S, Bootsma G, Chung C, Ménard C, Cho YB, Jaffray DA. Initial performance characterization and clinical implementation of a novel image-guided system for Perfexion. J Neurosurg, 2013.
113. Chung C, Tsao M, Lutz S. Conventional radiation therapy for brain metastases. J Radiat Oncol 1(3):211-219, 2012.
114. Chung C. Impact of Internal Mammary Node Irradiation in High-Risk Patients. Oncology Exchange 10(4):4-5, 2011.
115. Ibrahim GM, Chung C, Bernstein M. Competing for patients: an ethical framework for recruiting patient with brain tumors into clinical trials. J Neuro-oncol 104(3):623-7, 2011. PMID: 21318320.
116. Chung C, Dawson L, Joshua A, Brade A. Radiation Recall Dermatitis Triggered by Multi Tyrosine Kinase Inhibitors: Sunitinib and Sorafenib. Anti-Cancer Drugs 21(2):209-209, 2010. PMID: 19952730.
117. Chung C, Brade A. Radiosensitizers and anti-angiogenic agents for brain metastases. Journal of Pain Management 4(2):149-158, 2010.
118. Chung C, Al Ali J, Owen DA, Weiss AA, Yoshida EM, Tai IT. A rare case of isolated duodenal metastases from hepatocellular carcinoma associated with p53 and ki-67 expression: a case report. Cases J 2:9344, 2009. e-Pub 2009. PMID: 20062599.
119. Chung C, Al Ali J, Owen D, Weiss A, Yoshida E, Tai I. Slivers of Liver in the Distal Duodenum: A Rare Cause of Gastrointestinal Bleeding from Metastatic Hepatocellular Carcinoma. Cases Journal 2(9344), 2009.
120. Chung C, Stuart D, Keyes M. Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin). Case Rep Med 2009(307894), 2009. PMID: 19746202.
121. Berthelet E, Germain F, Chung C, Kumar D, Larsson S, Wong F, Kader H. Accelerated-simultaneous boost IMRT for locally advanced head and neck cancer: Analysis of outcomes and patterns of failure. Radiother Oncol 82:46-47, 2007.
122. Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ. National Patterns of Care in the Management of WHO Grade II and III Spinal Ependymomas. World Neurosurg. e-Pub 2019. PMID: 30641236.
123. Moraes FY, Winter J, Atenafu EG, Dasgputa A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB.. Outcomes following SRS for small- to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose. Neuro Oncol. e-Pub 2018.
124. Kwan JYY, Croke J, Panzarella T, Ubhi K, Fyles A, Koch A, Dinniwell R, Levin W, McCready D, Chung C, Liu F, Bender JL.. Personalizing Post-Treatment Cancer Care: A Cross-Sectional Survey Examining the Needs and Preferences of Well Breast Cancer Survivors. Current Oncology. e-Pub 2019. PMID: 31043819.
125. Julián-Serrano S, Yuan F, Wheeler W, Benyamin B, Machiela MJ, Arslan AA, Beane-Freeman LE, Bracci PM, Duell EJ, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Marchand LL, Neale RE, Shu XO, Van Den Eeden SK, Visvanathan K, Zheng W, Albanes D, Andreotti G, Ardanaz E, Babic A, Berndt SI, Brais LK, Brennan P, Bueno-de-Mesquita B, Buring JE, Chanock SJ, Childs EJ, Chung C, Fabiánová E, Foretová L, Fuchs CS, Gaziano JM, Gentiluomo M, Giovannucci EL, Goggins MG, Hackert T, Hartge P, Hassan MM, Holcátová I, Holly EA, Hung RI, Janout V, Kurtz RC, Lee IM, Malats N, McKean D, Milne RL, Newton CC, Oberg AL, Perdomo S, Peters U, Porta M, Rothman N, Schulze MB, Sesso HD, Silverman DT, Thompson IM, Wactawski-Wende J, Weiderpass E, Wenstzensen N, White E, Wilkens LR, Yu H, Zeleniuch-Jacquotte A, Zhong J, Kraft P, Li D, Campbell PT, Petersen GM, Wolpin BM, Risch HA, Amundadottir LT, Klein AP, Yu K, Stolzenberg-Solomon RZ. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. e-Pub 2021. PMID: 34258619.
126. Kwan JYY, Croke J, Panzarella T, Ubhi K, Liu FF, Fyles A, Koch A, Dinniwell R, Levin W, McCready D, Chung C, Bender J. Supportive Care Needs and Perceptions of Alternative Follow-up Care Options Among Well Breast Cancer Patients: A Cross-sectional Survey. Journal of Cancer Survivorship.
127. Naseem M, Barzi A, Brezden-Masley C, Chung C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, Lenz H. Ebstein-Barr virus associated gastric cancer: a comprehensive review. Cancer Res.
128. McGovern SL, Luo D, Johnson J, Nguyen K, Li J, McAleer MF, Yeboa D, Grosshans DR, Ghia AJ, Chung C, Bishop AJ, Song J, Thall PF, Brown PD, Mahajan A. A Prospective Study of Conventionally Fractionated Dose Constraints for Re-Irradiation of Primary Brain Tumors in Adults. Pract Radiat Oncol. e-Pub 2022. PMID: 36596356.
129. Hasanov M, Milton DR, Bea Davies A, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen R, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg J, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Neuro Oncol. e-Pub 2022. PMID: 36510640.
130. Xiao Y, Cardenas C, Rhee DJ, Netherton T, Zhang L, Nguyen C, Douglas R, Mumme R, Skett S, Patel T, Trauernicht C, Chung C, Simonds H, Aggarwal A, Court L. Customizable landmark-based field aperture design for automated whole-brain radiotherapy treatment planning. J Appl Clin Med Phys:e13839. e-Pub 2022. PMID: 36412092.
131. Lee KP, Koshelev MV, D3CODE Team, Pacha O. The effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the greater Houston area: A retrospective chart review. J Am Acad Dermatol. e-Pub 2022. PMID: 35016993.
132. Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, D3CODE Team. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract:OP2100819. e-Pub 2022. PMID: 35263166.
133. Chung C, Brown PD, Wefel JS. Lessons learned from proton vs photon radiation therapy for glioblastoma signal-finding trial. Neuro Oncol. e-Pub 2022. PMID: 35460425.

Invited Articles

1. Chung C, Kalpathy-Cramer J, Knopp MV, Jaffray DA. In the era of deep learning, why reconstruct an image at all?. J Am Coll Radiol 18(1 Pt B):170-173, 2021. PMID: 33413895.
2. Jaffray DA, Chung C, Coolens C, Foltz W, Keller H, Menard C, Milosevic M, Publicover J, Yeung I. Quantitative imaging in radiation oncology: An emerging science and clinical service. Semin Radiat Oncol 25(4):292-304, 2015. e-Pub 2015. PMID: 26384277.
3. Chung C, Laperriere N. How I treat glioblastoma. Clinical Practice 10(2):157-65, 2013.

Other Articles

1. Chung C New Hope for Brain Metastases. Connexions. RMP Newsletter 1, 2010.
2. Chung C, Jaffray D. Context is Everything: Foundational Data Management Principles to Realize IOM’s Learning Health System, Viewpoint. Lancet Digital Health.

Editorials

1. Omary RA, Chung C, Lee CI. The Provocative: A Glimpse Into Radiology's Future. J Am Coll Radiol 18(1 Pt B):137-139, 2021. PMID: 33413889.
2. Tawbi HA, Chung C, Margolin K.. Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. N Engl J Med 379(22):2178, 2018 Nov 29, 2018.
3. Chung C, Prasad D, Torrens M, Paddick I, Hanssens P, Kondziolka D, Jaffray DA. Editorial: Leksell Gamma Knife Society and Radiosurgery: A legacy and a vision for the future. Journal of Neurosurgery Suppl(129):2-4, 2018, 2018.
4. Johnson JM, Chung C. Glioblastoma: does PET shed light to a difficult problem?. Translational Cancer Research 5(S4), 2016.
5. Wazer DE, Hepel JT, Riker AI, Harness JK, Chung C, Khan AJ, Offersen BV, Poortmans P, Taghian A. In Regard to Vadiya et al. International Journal of Radiation Oncology Biology Physics 92(5):952-953, 2015.
6. Mackenzie P, Fyles A, Chung C. Radiotherapy for breast cancer, the TARGIT-A trial. Lancet 383(9930):1717, 2014.
7. Ruschin M, Komljenovic PT, Ansell S, Ménard C, Bootsma G, Cho YB, Chung C, Jaffray D. In reply to Cheung. Int J Radiat Oncol Biol Phys 85(2):291-2, 2013. PMID: 23312270.
8. Lee SL, Chung C. Experience of Attending the 2012 Annual ISMRM Scientific Conference. Ontario Medical Students Association Scrub-In Magazine, 2012.

Abstracts

1. Thrower S, Luo D, Brock K, Chung C.. MRI Slice Thickness Impacts the Detection and Treatment of Brain Metastases. Medical Physics 46(6):E309-E309, 2019.
2. Vedam S, Yang J, Fuller Cd, Chung C, Balter P, Lee B, Castillo P, Hughes N, Ungchusri G, McAleer M, Koong A, Herman J, Gillin M, Martel M, Wang J.. First MR-Guided Online Adaptive Patient Treatment in North America On An In-Room High Field (1.5 T) MRI Linac. Medical Physics 46(6):E229-E229, 2019.
3. Yang J, Vedam S, Wang J, Fuller CD, Choi S, Chung C, McAleer M, Lee B, Hughes N, Ungchusri G, Gillin M, Martel M, Balter P.. Clinical Experience of Patient-Specific QA for Online Adaptive Radiotherapy Using Elekta Unity MR-Linac. Medical Physics 46(6):E204-E204, 2019.
4. Chung C.. A Critical Look of Quantitative Dynamic Contrast Enhanced MRI: From QIBA guidelines to Clinical Implementation. Radiotherapy and Oncology 133:S240-S240, 2019.
5. Sandstrom H, Toma-Dasu I, Chung C, Jokura H, Dasu A.. Simultaneous truth and performance level estimation method for contouring assessment in radiosurgery. Radiotherapy and Oncology 133:S1011-S1011, 2019.
6. Yeboa D, Liao K, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines L, Ferguson S, Paulino A, Ghia A.. Patterns of Care in the Management of WHO Grade II and III Spinal Ependymomas. Radiotherapy and Oncology 133:S377-S377, 2019.
7. Elhalawani H, Li TF, Al Feghali K, Radwan S, Ding Y, Jin Y, Mohamed A, Fuller CD, Zhu HT, Chung C.. Early Evaluation of Radiation-induced White Matter Injury Following High Dose Fractionated Radiation Therapy in Patients with Glioblastoma Using Serial Diffusion Tensor Imaging (DTI). International Journal of Radiation Oncology Biology Physics 103(5):E28-E28, 2019.
8. Goldman J, Buszek S, Starr B, Al Feghali K, Chevli N, Allen P, Chung C.. Comparison of Outcomes and Optimal Treatments Between Unifocal and Multifocal Glioblastoma Using the National Cancer Database. International Journal of Radiation Oncology Biology Physics 103(5):E7-E7, 2019.
9. Elhalawani H, Li T, Radwan S, Al Feghali K, Ding Y, Mohamed A, Fuller CD, Zhu H, Chung C. Radiation-induced White Matter Injury Following Radiation Therapy in Glioblastoma patients. International Journal of Radiation Oncology Biology Physics 102(3):E216-E216, 2018.
10. Elhalawani H, Lin T, Al Feghali K, Radwan S, Chevli N, Mohamed A, Fuller CD, Chung C. Investigating Semi-Quantitative in-vivo Spatial and Dosimetric Analytical Algorithms to Report GBM Patterns of Failures following chemoradiation in the IMRT era 102(3):E241-E241, 2018.
11. Buszek SM, Al Feghali K, Elhalawani H, Chevli N, Allen P, Chung C. Predictors for and Clinical Impact of Time between Surgical Resection and Radiotherapy in Glioblastoma: Analysis of the National Cancer Database (2018). International Journal of Radiation Oncology Biology Physics 102(3):E260-E261, 2018.
12. Al Feghali K, Buszek SM, Elhalawani H, Chevli N, Allen PK, Chung C.. Real-Word Evaluation of the Impact of Radiotherapy and Chemotherapy in Elderly Patients with Glioblastoma based on Age and Performance Status: A National Cancer Database Analysis. Neuro-Oncology 20:117-117, 2018.
13. Al Feghali K, Elhalawani H, Buszek SM, Chevli NC, Allen PK, Chung C. Interplay of Age and Performance Status on Patterns of Care and Outcomes in Elderly Patients with Glioblastoma: A National Cancer Database Analysis. International Journal of Radiation Oncology Biology Physics 102(3):E201-E202, 2018.
14. Slagowski JM, Ding Y, Wen Z, Fuller CD, Chung C, Kadbi M, Ibbot GS, Wang J. Quantification of Geometric Distortion in Magnetic Resonance Imaging for Radiation Therapy Treatment Planning. International Journal of Radiation Oncology Biology Physics 102(3):E547-E547, 2018.
15. Anderson B, Elsohari B, Cardenas C, Mohamed A, Yang P, Fuller CD, Chung C, Brock K.. Deep Learning for Head and Neck Segmentation in MR: A Tool for the MR-Guided Radiotherapy. Medical Physics 45(6):E634-E364, 2018.
16. He R, Ding Y, Mohamed A, Elhalawani H, Ger R, Elgohari B, Wang J, Brock K, Chung C, Hutcheson K, Frank S, Lai S, Fuller CD.. Improve IVIM & DCE Map Using Convex Optimization with Higher-Order Total-Variation Regularizations. Medical Physics 45(6):E215-E215, 2018.
17. Netherton T, Cardenas C, Klopp A, Baker P, Chung C, Peterson C, Howell R, Court L.. Automated Detection of Vertebral Body Metastases for Fully-Automated Palliative Radiotherapy Using Transfer Learning. Medical Physics 45(6):E449-E449, 2018.
18. Winter J, Moraes F, Chung C, Coolens C.. Investigation of Dose-Correlated MR Biomarker Changes in Brain Metastases Post-SRS. Medical Physics 45(6):E580-E580, 2018.
19. Chung C, Brown P, Liu D, Grosshans D, Dibaj S, Guha-Thakurta N, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, De Groot J, Heimberger A, Wang J, Armstrong T, Giilbert M, Mahajan A, Wefel J. Ph II randomized trial comparing cognitive outcomes of proton vs. photon radiation for glioblastoma. Radiotherapy and Oncology 127:S687-S687, 2018.
20. Chung C. Challenges of MRI that have prevented adoption for dose painting and will persist for radiomics. Radiotherapy and Oncology 127:S9-S10, 2018.
21. Winter J, de Moraes FY, Chung C, Coolens C.. Early MRI biomarkers changes following SRS of brain metastases: correlation with dose. Radiotherapy and Oncology 127:S544-S545, 2018.
22. Schvartsman G, Glitza IC, Milton D, Amaria RN, Diab A, Hwu W, Patel SP, Wong MKK, Hwu P, Brown C, Beosch I, Burton E, Wefel J, Chung C, Davies MA, Tawbi HA. A phase II study of Study of Bevacizumab (BEV) in Combination With ATezolizumab (ATEZO) in Pts (pts) With Untreated and Symptomatic Melanoma Brain Metastases (BEAT-MBM). J Clin Oncol 36(Suppl):abstr TPS9598, 2018.
23. Hahn E, Velazquez-Martin JP, Somani S, Payne D, Waldron J, Krema H, Simpson R, Laperriere N, Chung C. Hypofractionated Palliative Radiation Therapy for Choroidal Metastases: Clinical Outcomes and Predictors of Overall Survival. International Journal of Radiation Oncology Biology Physics 96(2S):E510, 2016.
24. Ghobadi K, Aleman D, Li W, Chung C, Jaffray D. Continuous Dose Delivery wih Gamma Knife Perfexion. Medical Physics 42(6):3576, 2015.
25. Coolens C, Driscoll B, Foltz W, Chung C. Input function selection and T10 correction on DCE-MRI tumor response prediction using compared to volumetric DCE CT. Med Phys 42(6):3215, 2015. PMID: 26127196.
26. Brown PD, Asher AL, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG (II), Deming RL, Burris S, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Jaeckle KA.. NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases. Journal of Clinical Oncology 33(15 (Supl)), 2015.
27. Richard NM, Bernstein LJ, Mason WP, Laperriere N, Chung C, Millar BA, Maurice C, Edelstien K.. Rehabilitation of cognitive dysfunction in brain tumor patients. J Clin Oncol 33(15), 2015.
28. Tieu MT, Lovblom LE, McNamara M, Mason W, Laperriere N, Millar BA, Menard C, Kiehl TR, Perkins BA, Chung C. Impact of Glycemia on Survival in Glioblastoma Patients. J Neurooncol, 2015.
29. Lymberiou T, Galuszka S, Lee G, Xu W, Su S, Fyles A, Purdie T, Catton P, Chung C, Dinniwell R, Han K, Koch A. Levin W, Manchul L, Sappiatzer J, Mackenzie P, Liu FF. Predictors of breast radiotherapy plan modifications: Quality assurance rounds in a large cancer centre. Asia-Pacific Journal of Clinical Oncology 10:170, 2014.
30. Khoja L, Kurtz G, Zadeh G, Laperriere N, Menard C, Millar BA, Kongkham P, Joshua A, Hogg D, Butler M, Chung C. Increased acute radiation effect (ARE) with ipilumumab and radiosurgery in patients with melanoma brain metastases. Neuro-Oncology 16(Suppl 5), 2014.
31. McNamara M, Jiang H, Lim Fat M, Sahebjam S, Kiehl T, Karamchandani J, Coire C, Chung C, Miller BA, Laperriere N, Mason W.. Delaying radiotherapy in 1p19q co-deleted and partially deleted gliomas. Neuro-oncology 16(Suppl 5):v191, 2014.
32. Mason M, McNamara M, Tieu M, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Mason W, Chung C. Prognostic value of early changes in neutrophil and lymphocyte measures during chemoradiotherapy for glioblastoma. Neuro-Oncology 16:v191, 2014.
33. Kurtz G, Zadeh G, Gingras-Hill G, MIllar BA, Laperriere N, Bernstein M, Menard C, Chung C. Salvage Radiosurgery for Brain Metastases: Prolonged Survival with Durable Tumor Control. Int J Radiat Oncol Biol Phys 84(3):S825, 2014.
34. McNamara MG, Jiang H, Lim Fat MJ, Sahebjam S, Kiehl TR, Karamchandani J, Coire C, Chung C, Millar BA, Laperriere N, Mason W. Temozolomide for 1p19q co-deleted and partially deleted gliomas. Annals of Oncology 25(suppl_4), 2014.
35. Mason MT, McNamara MG, Tieu MT, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Mason WP, Chung C. Reduction in neutrophil-lymphocyte ratio during initial concurrent chemoradiotherapy is prognostic for survival of glioblastoma patients. Neuro-Oncology 16:ii23-ii24, 2014.
36. Chung C, Li W, Bootsma G, von Schultz O, Cho YB, Carlsson P, Jaffray D. Clinical Evaluation of a Novel Thermoplastic Mask System with Intrafraction Motion Monitoring using IR Tracking and Cone-beam CT for Gamma Knife® Radiosurgery. Int J Radiat Oncol Biol Phys 90(1):s848, 2014.
37. Li W, Cho YB, Hiemstra K, Jaffray DA, Chung C. Impact of Immobilization on Intrafraction Motion for Dedicated Cobalt Radiosurgery Unit Using Cone Beam Computed Tomography. Int J Radiat Oncol Biol Phys 90(1 Suppl 1):S896, 2014.
38. Lymberiou T, Galuszka S, Lee G, Xu W, Su S, Fyles A, Purdie T, Catton P, Chung C, Dinniwell R, Han K, Koch A, Levin W, Manchul L, Sappiatzer J, Mackenzie P, Liu F-F. Predictors of breast radiotherapy plan modifications: quality assurance rounds in a large cancer centre. Int J Radiat Oncol Biol Phys 90(S1):S254, 2014.
39. Ayala-Peacock D, Attia A, Hepel J, Lucas J, Onyeuku N, Stavas M, Taylor R, Chung C, Fiveash J, Chan M. A Multi-institutional Predictive Nomogram for Distant Brain Failure in Patients Treated with Upfront Stereotactic Radiosurgery Without Whole Brain Radiation Therapy. Int J Radiat Oncol Biol Phys 90(1):S126, 2014.
40. Adilman R, Rajmohan Y, Trinkaus M, Chung C, Naseem M, Hammad N, Leonard R, Urgoiti GR, Brooks E, Poonja Z, Simmons CE. Social media use amongst oncologists: Results of a national physician survey. Journal of Clinical Oncology 32(15 (Supl 1)), 2014.
41. Edelstein K, Laperriere N, Bernstein L, Simpson R, Chung C, Millar MA, Mason WP. Neurocognitive functions in adults treated with radiation for primary brain tumors: A longitudinal study. J Clin Oncol 32(5s), 2014.
42. Bender J, Singh Ubhi K, Alkazaz N, Catton P, Dinniwell R, Fyles A, Manchul L, Levin W, Liu FF, McCready D, Chung C. Low-risk Breast Cancer Patients’ Perceptions of Alternative Models of Survivorship Care. Radiotherap Oncol, 2013.
43. Menjak IB, Maki E, Chung C, Berman HK, McCready DR, Sridhar SS. Discordance of ER and PR status between primary and recurrent breast cancer in association with endocrine therapy. Cancer Research 73(Suppl 24), 2013.
44. Carlson R, Hiemstra K, Pearson S, Qiu X, Xu W, Fyles A, Chung C. Discovery and Validation of Simple Heart Measurements to Screen Patients Who Will Benefit from Deep Inspiration Breath Hold for Left Breast Irradiation. Cancer Research 73(24 supplement), 2013.
45. Vera-Bolanos E, Acquaye AA, Brown PD, Chung C, Gilbert MR, Vardy J, Armstrong TS. Structure and reliability of the dexamethasone symptom questionnaire-chronic in primary or metastatic brain tumor patients. Neuro-Oncology 15(iii233), 2013.
46. McNamara MG, Lwin Z, Jiang H, Chung C, Millar BA, Sahgal A, Laperriere N, Mason WP. Does time to first progression (TTP) impact post-progression survival in glioblastoma (GBM) in the temozolomide (TMZ) treatment era?. Neuro-Oncology 15(iii120), 2013.
47. Jalali S, Chung C, Burrell K, Foltz W, Zadeh G. Non-invasive MRI biomarkers of response to anti-angiogenic therapy in glioblastoma multiforme. Neuro-Oncology 15(iii4), 2013.
48. Menjak IB, Maki E, Berman HK, Chung C, McCready DR, Sridhar SS. Impact of endocrine therapy in early-stage breast cancer on time to locoregional recurrence. Journal of Clinical Oncology 31(26 Supl), 2013.
49. Chung C, Driscoll B, Gorjizadeh A, Foltz W, Lee S, Menard C, Coolens C. Early Detection of Tumor Response using 4D DCE-CT and DCE-MRI in Patients Treated with Radiosurgery for Brain Metastases. Practical Radiation Oncology 3(2 Supl):S17-18, 2013.
50. Stanescu T, Chung C, Menard C. Quantification of the magnetic susceptibility effects during MRI-guided radiosurgery of hemorrhagic brain metastases. Int J Radiat Oncol Biol Phys 84(3 Supl):S824-S825, 2012.
51. Heydarian M, Wilson G, van Prooijen M, Cho YB, Tamerou M, Chung C, Laperriere N, Jaffray D. Invasive Eye Fixation and Monitoring System for the Treatment of Choroidal Melanoma (CM) Using the Gamma Knife Perfexion (GK). Int J Radiat Oncol Biol Phys 84(3 Supl):S285, 2012.
52. Chung C, Menard C, Stevens C, Laperriere N, Millar BA, Bernstein M, Zadeh G, Mason W, Brade A. Phase I Dose Escalation Study of Sunitinib and Radiosurgery for Brain Metastases. Int J Radiat Oncol Biol Phys 84(3 Supl):S77, 2012.
53. Chung C, Menard C, Stevens C, Laperriere N, Millar BA, Bernstein M, Zadeh G, Mason W, Brade A. Phase I Dose Escalation Study of Sunitinib and Radiosurgery for Brain Metastases. Radiotherapy and Oncology 104:S71, 2012.
54. Lee SL, Foltz W, Driscoll B, Fatemi A, Ménard C, Coolens C, Chung C. Comparison of Arterial Input Functions by Magnitude and Phase Signal Measurement in Dynamic Contrast Enhancement MRI using a Dynamic Flow Phantom. Magn Reson Med, 2012.
55. Herrmann E, Krema, Chung C. Radiotherapy for treatment of basal cell carcinoma of the medial canthal region. Radiotherapy and Oncology 103:S478, 2012.
56. Jalali S, Foltz W, Burrell K, Chung C, Zadeh G. Identification of MRI biomarkers and histopathological alterations in response to combination therapy with antiangiogenic agents and radiation in a murine model of glioma tumor, Part B, Skull Base. Journal of Neurological Surgery, 2012.
57. Ruschin M, De Jean P, Ansell S, Bootsma G, Chung C, Ménard C, Cho YB, Jaffray D. Initial performance characterization and clinical implementation of a novel image-guided system for Perfexion. J Neurosurg, 2012.
58. Chung C, Millar BA, Menard C, Zadeh G, Bernstein M, Laperriere N. Radiosurgery for Brainstem Metastases. J Neurosurg, 2012.
59. Jalali S, Foltz W, Burrell K, Lee JI, Agnihorti S, Menard C, Chung C, Zadeh G. Identification of MRI biomarkers and histopathological alterations in response to combinatorial therapy with sunitinib and radiation in a murine model of glioma. Neuro-Oncology 13:iii6-iii7, 2011.
60. Li W, Ruschin M, Tamerou M, Cho YB, Chung C, Ménard C, Jaffray D. Evaluating setup reproducibility between a CT planning and gamma knife radiosurgery couch using a relocatable head frame. Int J Radiat Oncol Biol Phys 81(2):S87, 2011.
61. Ruschin ME, Komlijenovic PT, Cho Y, Chung C, Menard C, Jaffray D. A novel prototype for image-guidance on a dedicated radiosurgery treatment unit. Int J Radiat Oncol Biol Phys 81(2):S60, 2011.
62. Brade AM, Kim SW, Chung C, Wan JF, Southwood B, Chaudary N, Wang L, Milosevic M, Oza AM. Final results: A phase I study of sorafenib and palliative radiation in patients with malignancy in the thorax, abdomen or pelvis. Journal of Clinical Oncology 29(15 Suppl), 2011.
63. Chung C, Foltz W, Lindsay P, Burrell K, Kallehauge J, Wildgoose P, Camphausen K, Jaffray D, Zadeh G, Menard C. Intracranial murine tumor investigation of radiation and antiangiogenic agents using serial MRI 78(3 Suppl):S663, 2010.
64. Chung C, Foltz W, Wildgoose P, Burrell K, Lindsay P, Kallehauge J, Camphausen K, Kassner A, Jaffray DA, Menard C, Zadeh G. Biomarker evaluation during an image-guided intracranial murine glioma study of radiation and sunitinib. Cancer Res 70(8 Suppl), 2010.
65. Chung C, Foltz W, Lindsay P, Burrell K, Kallehauge J, Wildgoose P, Camphausen K, Jaffray D, Zadeh G, Menard C. Intracranial murine tumor investigation of radiation and antiangiogenic agents using serial MRI. International Journal of Radiation Oncology Biology Physics 78(3 Suppl 1):S663, 2010.
66. Berthelet E, Germain F, Chung C, Kumar D, Larsson S, Wong F, Kader H. Accelerated-simultaneous boost imrt for locally advanced head and neck cancer: Analysis of outcomes and patterns of failure 82(S1):S46-S47, 2007.
67. Chung C, Knight B, Peters C, Malloff C, Lam W, Sheehan F. Detection of circulating tumour cells from peripheral blood samples by a novel cell concentration method and immunohistochemistry (IHC) compared with reverse transcriptase-polymerase chain reaction (RT-PCR) in Stage III/IV Non-small cell lung cancer (NSCLC). J Thorac Oncol 2(8):S408, 2007.
68. Chung C, Weir L, Bergman A, Kwa W, Welsh M, Fong M, Popescu IA. Improved dose calculation with Monte Carlo for internal mammary nodal irradiation for breast cancer. Radiother Oncol 81(Suppl 1):S1, S1-533, 2006.
69. Berthelet E, Truong P, Chung C, Moravan V, Wong F, Kwan W, Currie T, Patterson K, Olivotto I. Preliminary Validation of the RTOG Acute Skin Toxicity Scoring System in Patients Undergoing Adjuvant Radiotherapy for Breast Cancer. Radiother Oncol 76(S1), 2005.
70. Chung C, Keyes M, Kwa W, Weir L, Parsons C. Adjuvant Axillary Radiotherapy for Breast Cancer: Is CT Planning with Nodal Contouring Better Than Traditional Planning?. Radiother Oncol 76(1):S10, 2005.
71. Berthelet E, Truong P, Chung C, Moravan V, Wong F, Kwan W, Curne T, Patterson K, Olivotto I. Preliminary Validation of the RTOG Acute Skin Toxicity Scoring System in Patients Undergoing Adjuvant Radiotherapy for Breast Cancer. Radiother Oncol 76(1):S12, 2005.
72. Chung C, Berthelet E, Truong P, Wong F, Currie T, Kwan W, Patterson K. The Effect of Vitamin E Cream on Acute Skin Toxicity During Adjuvant Radiotherapy for Breast Cancer. Radiother Oncol 73(S1), 2005.
73. Chung C, Keyes, Kwa W, Weir L, Parsons C. Adjuvant Axillary Radiotherapy for Breast Cancer: Is CT Planning with Nodal Contouring Better Than Traditional Planning?. Radiother Oncol 76(S1), 2005.
74. Slagowski JM, Ding Y, Aima M, Wen Z, Fuller CD, Chung C, Debnam JM, Hwang KP, Kadbi M, Szklaruk J, Wang J. A modular phantom and software to characterize 3D geometric distortion in MRI. Phys Med Biol. e-Pub 2020. PMID: 32531763.

Book Chapters

1. Buszek SM, Chung C. Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-Randomized Trials. In: Front Oncol, 1224, 2019.
2. Mawrin C, Chung C, Preusser M. Biology and clinical management challenges in meningioma. In: In: Am Soc Clin Oncol Educ Book. 35, 106-15, 2015.
3. Chung C. Imaging biomarkers in preclinical studies on brain tumours'. In: Biomarkers in Disease: Methods, Discovers and Applications -- Biomarkers in Cancer. Springer, 2014.
4. Chung C, Nam D, Stupp R. CNS Tumors. In: Union for International Cancer Control (UICC) Manual of Clinical Oncology, 2014.
5. Chung C, Chang E. Primary Tumors of the Central Nervous System. In: Radiation Oncology in Palliative Cancer Care. 1. John Wiley & Sons, Ltd, 2013.
6. Chung C, Laperriere N. Management of Intracranial Metastases. In: Principles and Practice of Palliative Care and Supportive Oncology. 4. Philadelphia: Lippincott Williams & Wilkins, 2012.
7. Chung C, Brade A. Radiosensitizers and Anti-angiogenic agents for brain metastases. In: Bone and Brain Metastases: Advances in research and treatment. New York: Nova Science Publishers, Inc, 2010.